← FDA Drug Approvals (Drugs@FDA)
DALIRESP
NDA · New Drug Application · Sponsor: ASTRAZENECA · Approved 2011-02-28
Drug application
- FDA Application #
NDA022522- Application type
- New Drug Application
- Brand name
- DALIRESP
- Generic name
- ROFLUMILAST
- Active ingredients
- ROFLUMILAST
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ASTRAZENECA
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- First approval
- 2011-02-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown